EMEA-001354-PIP01-12
Key facts
| Active substance |
2,6-Bis-{(1-napthalenyl-3,6-disulfonic acid)-oxyacetamido}-2,6-bis-2,6-bis-2,6-bis-(2,6-diamino-hexanoylamino)-2,6-diamino-hexanoic acid (diphenylmethyl)-amide, polysodium salt
|
| Therapeutic area |
Other
|
| Decision number |
P/0033/2013
|
| PIP number |
EMEA-001354-PIP01-12
|
| Pharmaceutical form(s) |
Vaginal gel
|
| Condition(s) / indication(s) |
Treatment of bacterial vaginosis
|
| Route(s) of administration |
Vaginal use
|
| Contact for public enquiries |
Starpharma Pty Ltd
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|